comparemela.com
  1. Home
  2. Live Updates
  3. Company Or Canntab - Breaking News

Latest Breaking News On - Company or canntab - Page 4 : comparemela.com

CANNTAB OFFICIALLY LAUNCHES ITS ONLINE E-COMMERCE PLATFORM

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene.

Larry latowskyOntario cannabisCanntab therapeutics incHealth canada onCompany or canntabCanntab therapeutics limitedCannabis researchCanntab therapeuticsFrankfurt stock exchangeCanadian securities exchangeTherapeutics limitedMedical sales licenseHealth canadaCannabis standard processingMedical purposes license

CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

/PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and.

Larry latowskyOntario cannabis storeHealth canada onCompany or canntabCannabis researchFrankfurt stock exchangeCanntab therapeuticsCanadian securities exchangeHealth canadaCanntab therapeutics limitedChief executive officerOntario cannabisMedical sales licenseCannabis standard processingMedical purposes licenseCannabis research license

CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

/PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and.

Larry latowskyOntario cannabis storeHealth canada onCompany or canntabCannabis researchFrankfurt stock exchangeCanntab therapeuticsCanadian securities exchangeHealth canadaCanntab therapeutics limitedChief executive officerOntario cannabisMedical sales licenseCannabis standard processingMedical purposes licenseCannabis research license

CANNTAB DELIVERS 1st SHIPMENT TO THE ONTARIO CANNABIS STORE AND 2nd SHIPMENT TO AUSTRALIA

TORONTO, Jan. 10, 2022 /PRNewswire/ - Canntab Therapeutics Limited   , a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is. | January 10, 2022

Larry latowskyOntario cannabis storeHealth canada onCompany or canntabCannabis researchFrankfurt stock exchangeCanntab therapeuticsCanadian securities exchangeHealth canadaCanntab therapeutics limitedChief executive officerOntario cannabisMedical sales licenseCannabis standard processingMedical purposes licenseCannabis research license

CANNTAB ENTERS INTO STRATEGIC PARTNERSHIP TO PROVIDE ALTERNATIVES TO OPIATES THROUGH LEVITEE CLINICS

/PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and.

United statesUnited kingdomNoha elsayedLarry latowskyCompany or canntabCanntab therapeutics limitedCannabis researchFrankfurt stock exchangeCanntab therapeuticsCanadian securities exchangeHealth canadaLevitee clinics incLevitee clinicsBoth canntabExecutive directorLevitee pharmacies

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.